We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Co Diagnostics Inc | NASDAQ:CODX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.03 | 2.59% | 1.19 | 1.15 | 1.24 | 1.20 | 1.14 | 1.14 | 27,200 | 21:23:04 |
NEW YORK, Sept. 16, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Co-Diagnostics, Inc. (NASDAQ: CODX).
To receive updates on the lawsuit, fill out the form:
https://claimyourloss.com/securities/co-diagnostics-inc-loss-submission-form-2/?id=31782&from=4
This lawsuit is on behalf of a class of all persons and entities who purchased the publicly traded securities of Co-Dx during the period of May 12, 2022 through the close of the market on August 11, 2022 (4:00 p.m. ET).
Shareholders interested in acting as a lead plaintiff representing the class of wronged shareholders have until October 17, 2022 to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
According to a filed complaint, Co-Diagnostics, Inc. issued materially false and/or misleading statements and/or failed to disclose that: (i) demand for the Company's Logix Smartâ„¢ COVID-19 test had plummeted throughout the quarter ended June 30, 2022, and (ii) as a result, defendants' positive statements about the demand for its Logix Smartâ„¢ COVID-19 test lacked a reasonable basis.
Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887
View original content:https://www.prnewswire.com/news-releases/codx-shareholder-alert-jakubowitz-law-reminds-co-dx-shareholders-of-a-lead-plaintiff-deadline-of-october-17-2022-301625743.html
SOURCE Jakubowitz Law
Copyright 2022 PR Newswire
1 Year Co Diagnostics Chart |
1 Month Co Diagnostics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions